Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ABBVIE ENDOCRINE INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve LEUPROLIDE ACETATE

Comment Full text

NOVAST LABS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 29
  • 0 comments

FDA approve IRINOTECAN HYDROCHLORIDE

Comment Full text

ETHYPHARM USA CORP

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 27
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

LANNETT CO INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 30
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

OREXO US INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 30
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

DR REDDYS LABS SA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 29
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

SUN PHARM

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 25
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 32
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

RHODES PHARMS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 29
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 18
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text
  • Previous
  • 497
  • 498
  • 499
  • 500
  • 501
  • Next

Search

News categories

  • Technical Exchange News(11746)
  • Event(4196)
  • SEC News(234428)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143026)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin